U.S. Physical Therapy, Inc. (NYSE:USPH) COO Graham D. Reeve Sells 1,730 Shares of Stock

U.S. Physical Therapy, Inc. (NYSE:USPH) COO Graham D. Reeve sold 1,730 shares of the business’s stock in a transaction on Friday, March 7th. The shares were sold at an average price of $82.11, for a total value of $142,050.30. Following the sale, the chief operating officer now owns 7,168 shares in the company, valued at approximately $588,564.48. The trade was a 19.44 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

U.S. Physical Therapy Stock Down 2.9 %

Shares of NYSE USPH opened at $80.61 on Friday. The firm has a 50-day simple moving average of $87.42 and a two-hundred day simple moving average of $87.51. U.S. Physical Therapy, Inc. has a 1 year low of $76.18 and a 1 year high of $113.63. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.78. The company has a market cap of $1.22 billion, a P/E ratio of 85.76, a PEG ratio of 3.54 and a beta of 1.48.

U.S. Physical Therapy (NYSE:USPH) last released its earnings results on Wednesday, February 26th. The company reported $0.65 earnings per share for the quarter, missing the consensus estimate of $0.69 by ($0.04). U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The company had revenue of $180.45 million for the quarter, compared to analysts’ expectations of $173.10 million. Research analysts anticipate that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current year.

U.S. Physical Therapy Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 14th will be issued a dividend of $0.45 per share. This is a boost from U.S. Physical Therapy’s previous quarterly dividend of $0.44. This represents a $1.80 annualized dividend and a dividend yield of 2.23%. The ex-dividend date is Friday, March 14th. U.S. Physical Therapy’s payout ratio is currently 97.83%.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on the stock. Barrington Research reduced their price target on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an “outperform” rating for the company in a research report on Friday, February 28th. StockNews.com lowered U.S. Physical Therapy from a “hold” rating to a “sell” rating in a research note on Friday, February 28th. JPMorgan Chase & Co. upped their price objective on shares of U.S. Physical Therapy from $117.00 to $120.00 and gave the company an “overweight” rating in a research note on Tuesday, December 3rd. Citizens Jmp raised shares of U.S. Physical Therapy to a “strong-buy” rating in a research note on Monday, December 16th. Finally, JMP Securities started coverage on shares of U.S. Physical Therapy in a report on Monday, December 16th. They set an “outperform” rating and a $113.00 price target for the company. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, four have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, U.S. Physical Therapy presently has an average rating of “Moderate Buy” and an average target price of $111.50.

Institutional Trading of U.S. Physical Therapy

Several institutional investors have recently added to or reduced their stakes in the stock. BNP Paribas Financial Markets lifted its position in shares of U.S. Physical Therapy by 283.0% during the 3rd quarter. BNP Paribas Financial Markets now owns 16,842 shares of the company’s stock worth $1,425,000 after buying an additional 12,445 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in U.S. Physical Therapy by 57.1% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,631 shares of the company’s stock worth $223,000 after acquiring an additional 956 shares during the period. State Street Corp raised its position in U.S. Physical Therapy by 17.5% during the 3rd quarter. State Street Corp now owns 667,868 shares of the company’s stock worth $56,522,000 after buying an additional 99,244 shares during the last quarter. Stifel Financial Corp lifted its position in U.S. Physical Therapy by 12.1% in the third quarter. Stifel Financial Corp now owns 57,166 shares of the company’s stock valued at $4,838,000 after purchasing an additional 6,154 shares during the period. Finally, Quest Partners LLC lifted its position in U.S. Physical Therapy by 2,368.2% during the third quarter. Quest Partners LLC now owns 8,614 shares of the company’s stock worth $729,000 after buying an additional 8,265 shares during the period.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.